nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR2B—cardial valve—systemic scleroderma	0.0579	0.227	CbGeAlD
Cabergoline—HTR7—myenteric nerve plexus—systemic scleroderma	0.0283	0.111	CbGeAlD
Cabergoline—HTR7—pulmonary artery—systemic scleroderma	0.0201	0.0786	CbGeAlD
Cabergoline—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0177	0.0693	CbGeAlD
Cabergoline—HTR2A—pulmonary artery—systemic scleroderma	0.0125	0.049	CbGeAlD
Cabergoline—HTR1B—artery—systemic scleroderma	0.00964	0.0378	CbGeAlD
Cabergoline—HTR1D—artery—systemic scleroderma	0.00934	0.0366	CbGeAlD
Cabergoline—HTR1B—blood vessel—systemic scleroderma	0.00751	0.0294	CbGeAlD
Cabergoline—HTR7—artery—systemic scleroderma	0.00744	0.0292	CbGeAlD
Cabergoline—HTR1D—blood vessel—systemic scleroderma	0.00727	0.0285	CbGeAlD
Cabergoline—HTR7—endothelium—systemic scleroderma	0.00628	0.0246	CbGeAlD
Cabergoline—HTR7—blood vessel—systemic scleroderma	0.00579	0.0227	CbGeAlD
Cabergoline—HTR2A—artery—systemic scleroderma	0.00464	0.0182	CbGeAlD
Cabergoline—HTR2A—endothelium—systemic scleroderma	0.00392	0.0154	CbGeAlD
Cabergoline—HTR1D—connective tissue—systemic scleroderma	0.00373	0.0146	CbGeAlD
Cabergoline—ADRB1—connective tissue—systemic scleroderma	0.00362	0.0142	CbGeAlD
Cabergoline—HTR2A—blood vessel—systemic scleroderma	0.00361	0.0142	CbGeAlD
Cabergoline—HTR2B—smooth muscle tissue—systemic scleroderma	0.00317	0.0124	CbGeAlD
Cabergoline—HTR2B—skin of body—systemic scleroderma	0.00313	0.0123	CbGeAlD
Cabergoline—HTR7—connective tissue—systemic scleroderma	0.00297	0.0116	CbGeAlD
Cabergoline—HTR7—smooth muscle tissue—systemic scleroderma	0.00272	0.0107	CbGeAlD
Cabergoline—HTR2B—digestive system—systemic scleroderma	0.00251	0.00982	CbGeAlD
Cabergoline—HTR2B—tendon—systemic scleroderma	0.00238	0.00935	CbGeAlD
Cabergoline—ADRB1—lung—systemic scleroderma	0.00219	0.00857	CbGeAlD
Cabergoline—ADRA2A—connective tissue—systemic scleroderma	0.00218	0.00854	CbGeAlD
Cabergoline—HTR7—digestive system—systemic scleroderma	0.00215	0.00841	CbGeAlD
Cabergoline—HTR2B—lung—systemic scleroderma	0.00209	0.0082	CbGeAlD
Cabergoline—HTR7—tendon—systemic scleroderma	0.00204	0.008	CbGeAlD
Cabergoline—ADRA2C—tendon—systemic scleroderma	0.00188	0.00736	CbGeAlD
Cabergoline—HTR2A—connective tissue—systemic scleroderma	0.00185	0.00726	CbGeAlD
Cabergoline—HTR7—lung—systemic scleroderma	0.00179	0.00702	CbGeAlD
Cabergoline—HTR2A—smooth muscle tissue—systemic scleroderma	0.00169	0.00664	CbGeAlD
Cabergoline—DRD2—lung—systemic scleroderma	0.00169	0.00664	CbGeAlD
Cabergoline—ADRA2C—lung—systemic scleroderma	0.00165	0.00646	CbGeAlD
Cabergoline—ADRA2A—tendon—systemic scleroderma	0.0015	0.00587	CbGeAlD
Cabergoline—HTR2A—digestive system—systemic scleroderma	0.00134	0.00524	CbGeAlD
Cabergoline—ADRA2A—lung—systemic scleroderma	0.00131	0.00515	CbGeAlD
Cabergoline—HTR2A—tendon—systemic scleroderma	0.00127	0.00499	CbGeAlD
Cabergoline—CYP3A4—digestive system—systemic scleroderma	0.00124	0.00486	CbGeAlD
Cabergoline—HTR2A—lung—systemic scleroderma	0.00112	0.00438	CbGeAlD
Cabergoline—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000968	0.0013	CcSEcCtD
Cabergoline—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000964	0.00129	CcSEcCtD
Cabergoline—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000958	0.00129	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000956	0.00128	CcSEcCtD
Cabergoline—Confusional state—Mycophenolic acid—systemic scleroderma	0.000953	0.00128	CcSEcCtD
Cabergoline—Abdominal pain—Captopril—systemic scleroderma	0.00095	0.00128	CcSEcCtD
Cabergoline—Oedema—Mycophenolic acid—systemic scleroderma	0.000945	0.00127	CcSEcCtD
Cabergoline—Anorexia—Leflunomide—systemic scleroderma	0.000944	0.00127	CcSEcCtD
Cabergoline—Nausea—Pentoxifylline—systemic scleroderma	0.000942	0.00126	CcSEcCtD
Cabergoline—Malaise—Lisinopril—systemic scleroderma	0.00094	0.00126	CcSEcCtD
Cabergoline—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000938	0.00126	CcSEcCtD
Cabergoline—Vertigo—Lisinopril—systemic scleroderma	0.000937	0.00126	CcSEcCtD
Cabergoline—Diarrhoea—Mometasone—systemic scleroderma	0.000936	0.00126	CcSEcCtD
Cabergoline—Syncope—Lisinopril—systemic scleroderma	0.000935	0.00126	CcSEcCtD
Cabergoline—Shock—Mycophenolic acid—systemic scleroderma	0.00093	0.00125	CcSEcCtD
Cabergoline—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000928	0.00125	CcSEcCtD
Cabergoline—Hypotension—Leflunomide—systemic scleroderma	0.000926	0.00124	CcSEcCtD
Cabergoline—Palpitations—Lisinopril—systemic scleroderma	0.000922	0.00124	CcSEcCtD
Cabergoline—Loss of consciousness—Lisinopril—systemic scleroderma	0.000917	0.00123	CcSEcCtD
Cabergoline—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000914	0.00123	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000902	0.00121	CcSEcCtD
Cabergoline—Anorexia—Mycophenolic acid—systemic scleroderma	0.000901	0.00121	CcSEcCtD
Cabergoline—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.0009	0.00121	CcSEcCtD
Cabergoline—Tension—Mycophenolate mofetil—systemic scleroderma	0.000897	0.0012	CcSEcCtD
Cabergoline—Insomnia—Leflunomide—systemic scleroderma	0.000896	0.0012	CcSEcCtD
Cabergoline—Paraesthesia—Leflunomide—systemic scleroderma	0.000889	0.00119	CcSEcCtD
Cabergoline—Arthralgia—Lisinopril—systemic scleroderma	0.000888	0.00119	CcSEcCtD
Cabergoline—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000887	0.00119	CcSEcCtD
Cabergoline—Anxiety—Lisinopril—systemic scleroderma	0.000885	0.00119	CcSEcCtD
Cabergoline—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000884	0.00119	CcSEcCtD
Cabergoline—Dyspnoea—Leflunomide—systemic scleroderma	0.000883	0.00119	CcSEcCtD
Cabergoline—Hypotension—Mycophenolic acid—systemic scleroderma	0.000883	0.00119	CcSEcCtD
Cabergoline—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000879	0.00118	CcSEcCtD
Cabergoline—Discomfort—Lisinopril—systemic scleroderma	0.000877	0.00118	CcSEcCtD
Cabergoline—Dyspepsia—Leflunomide—systemic scleroderma	0.000872	0.00117	CcSEcCtD
Cabergoline—Vomiting—Mometasone—systemic scleroderma	0.00087	0.00117	CcSEcCtD
Cabergoline—Dry mouth—Lisinopril—systemic scleroderma	0.000868	0.00117	CcSEcCtD
Cabergoline—Sweating increased—Prednisone—systemic scleroderma	0.000866	0.00116	CcSEcCtD
Cabergoline—Feeling abnormal—Azathioprine—systemic scleroderma	0.000864	0.00116	CcSEcCtD
Cabergoline—Rash—Mometasone—systemic scleroderma	0.000863	0.00116	CcSEcCtD
Cabergoline—Asthenia—Captopril—systemic scleroderma	0.000862	0.00116	CcSEcCtD
Cabergoline—Dermatitis—Mometasone—systemic scleroderma	0.000862	0.00116	CcSEcCtD
Cabergoline—Decreased appetite—Leflunomide—systemic scleroderma	0.000861	0.00116	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000861	0.00116	CcSEcCtD
Cabergoline—Osteoarthritis—Methotrexate—systemic scleroderma	0.00086	0.00115	CcSEcCtD
Cabergoline—Confusional state—Lisinopril—systemic scleroderma	0.000858	0.00115	CcSEcCtD
Cabergoline—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000858	0.00115	CcSEcCtD
Cabergoline—Headache—Mometasone—systemic scleroderma	0.000857	0.00115	CcSEcCtD
Cabergoline—Insomnia—Mycophenolic acid—systemic scleroderma	0.000855	0.00115	CcSEcCtD
Cabergoline—Fatigue—Leflunomide—systemic scleroderma	0.000854	0.00115	CcSEcCtD
Cabergoline—Oedema—Lisinopril—systemic scleroderma	0.000851	0.00114	CcSEcCtD
Cabergoline—Pruritus—Captopril—systemic scleroderma	0.00085	0.00114	CcSEcCtD
Cabergoline—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000849	0.00114	CcSEcCtD
Cabergoline—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000848	0.00114	CcSEcCtD
Cabergoline—Pain—Leflunomide—systemic scleroderma	0.000847	0.00114	CcSEcCtD
Cabergoline—Constipation—Leflunomide—systemic scleroderma	0.000847	0.00114	CcSEcCtD
Cabergoline—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000842	0.00113	CcSEcCtD
Cabergoline—Somnolence—Mycophenolic acid—systemic scleroderma	0.00084	0.00113	CcSEcCtD
Cabergoline—Shock—Lisinopril—systemic scleroderma	0.000837	0.00112	CcSEcCtD
Cabergoline—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000832	0.00112	CcSEcCtD
Cabergoline—Abdominal pain—Azathioprine—systemic scleroderma	0.000829	0.00111	CcSEcCtD
Cabergoline—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000824	0.00111	CcSEcCtD
Cabergoline—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000823	0.0011	CcSEcCtD
Cabergoline—Diarrhoea—Captopril—systemic scleroderma	0.000822	0.0011	CcSEcCtD
Cabergoline—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000821	0.0011	CcSEcCtD
Cabergoline—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000821	0.0011	CcSEcCtD
Cabergoline—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000819	0.0011	CcSEcCtD
Cabergoline—Feeling abnormal—Leflunomide—systemic scleroderma	0.000816	0.0011	CcSEcCtD
Cabergoline—Fatigue—Mycophenolic acid—systemic scleroderma	0.000815	0.00109	CcSEcCtD
Cabergoline—Nausea—Mometasone—systemic scleroderma	0.000813	0.00109	CcSEcCtD
Cabergoline—Anorexia—Lisinopril—systemic scleroderma	0.000811	0.00109	CcSEcCtD
Cabergoline—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00081	0.00109	CcSEcCtD
Cabergoline—Weight increased—Prednisone—systemic scleroderma	0.000809	0.00109	CcSEcCtD
Cabergoline—Constipation—Mycophenolic acid—systemic scleroderma	0.000808	0.00108	CcSEcCtD
Cabergoline—Pain—Mycophenolic acid—systemic scleroderma	0.000808	0.00108	CcSEcCtD
Cabergoline—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000807	0.00108	CcSEcCtD
Cabergoline—Weight decreased—Prednisone—systemic scleroderma	0.000804	0.00108	CcSEcCtD
Cabergoline—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000803	0.00108	CcSEcCtD
Cabergoline—Hypotension—Lisinopril—systemic scleroderma	0.000795	0.00107	CcSEcCtD
Cabergoline—Dizziness—Captopril—systemic scleroderma	0.000795	0.00107	CcSEcCtD
Cabergoline—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000794	0.00107	CcSEcCtD
Cabergoline—Depression—Prednisone—systemic scleroderma	0.00079	0.00106	CcSEcCtD
Cabergoline—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000789	0.00106	CcSEcCtD
Cabergoline—Abdominal pain—Leflunomide—systemic scleroderma	0.000783	0.00105	CcSEcCtD
Cabergoline—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000779	0.00105	CcSEcCtD
Cabergoline—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000778	0.00104	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000775	0.00104	CcSEcCtD
Cabergoline—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000775	0.00104	CcSEcCtD
Cabergoline—Hypersensitivity—Azathioprine—systemic scleroderma	0.000773	0.00104	CcSEcCtD
Cabergoline—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000773	0.00104	CcSEcCtD
Cabergoline—Insomnia—Lisinopril—systemic scleroderma	0.00077	0.00103	CcSEcCtD
Cabergoline—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000769	0.00103	CcSEcCtD
Cabergoline—Paraesthesia—Lisinopril—systemic scleroderma	0.000764	0.00103	CcSEcCtD
Cabergoline—Vomiting—Captopril—systemic scleroderma	0.000764	0.00103	CcSEcCtD
Cabergoline—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000761	0.00102	CcSEcCtD
Cabergoline—Dyspnoea—Lisinopril—systemic scleroderma	0.000759	0.00102	CcSEcCtD
Cabergoline—Rash—Captopril—systemic scleroderma	0.000758	0.00102	CcSEcCtD
Cabergoline—Dermatitis—Captopril—systemic scleroderma	0.000757	0.00102	CcSEcCtD
Cabergoline—Somnolence—Lisinopril—systemic scleroderma	0.000757	0.00102	CcSEcCtD
Cabergoline—Headache—Captopril—systemic scleroderma	0.000753	0.00101	CcSEcCtD
Cabergoline—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000752	0.00101	CcSEcCtD
Cabergoline—Dyspepsia—Lisinopril—systemic scleroderma	0.000749	0.00101	CcSEcCtD
Cabergoline—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000747	0.001	CcSEcCtD
Cabergoline—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000746	0.001	CcSEcCtD
Cabergoline—Decreased appetite—Lisinopril—systemic scleroderma	0.00074	0.000993	CcSEcCtD
Cabergoline—Fatigue—Lisinopril—systemic scleroderma	0.000734	0.000985	CcSEcCtD
Cabergoline—Shock—Mycophenolate mofetil—systemic scleroderma	0.000734	0.000985	CcSEcCtD
Cabergoline—Hypersensitivity—Leflunomide—systemic scleroderma	0.00073	0.00098	CcSEcCtD
Cabergoline—Pain—Lisinopril—systemic scleroderma	0.000728	0.000977	CcSEcCtD
Cabergoline—Constipation—Lisinopril—systemic scleroderma	0.000728	0.000977	CcSEcCtD
Cabergoline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000721	0.000968	CcSEcCtD
Cabergoline—Diarrhoea—Azathioprine—systemic scleroderma	0.000718	0.000963	CcSEcCtD
Cabergoline—Nausea—Captopril—systemic scleroderma	0.000714	0.000958	CcSEcCtD
Cabergoline—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000712	0.000956	CcSEcCtD
Cabergoline—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000711	0.000954	CcSEcCtD
Cabergoline—Asthenia—Leflunomide—systemic scleroderma	0.000711	0.000954	CcSEcCtD
Cabergoline—Hallucination—Prednisone—systemic scleroderma	0.000708	0.00095	CcSEcCtD
Cabergoline—Feeling abnormal—Lisinopril—systemic scleroderma	0.000701	0.000942	CcSEcCtD
Cabergoline—Pruritus—Leflunomide—systemic scleroderma	0.000701	0.000941	CcSEcCtD
Cabergoline—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000697	0.000935	CcSEcCtD
Cabergoline—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000696	0.000934	CcSEcCtD
Cabergoline—Dizziness—Azathioprine—systemic scleroderma	0.000694	0.000931	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00069	0.000927	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000679	0.000912	CcSEcCtD
Cabergoline—Asthenia—Mycophenolic acid—systemic scleroderma	0.000678	0.00091	CcSEcCtD
Cabergoline—Diarrhoea—Leflunomide—systemic scleroderma	0.000678	0.00091	CcSEcCtD
Cabergoline—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000675	0.000905	CcSEcCtD
Cabergoline—Abdominal pain—Lisinopril—systemic scleroderma	0.000673	0.000903	CcSEcCtD
Cabergoline—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00067	0.000899	CcSEcCtD
Cabergoline—Pruritus—Mycophenolic acid—systemic scleroderma	0.000669	0.000897	CcSEcCtD
Cabergoline—Vomiting—Azathioprine—systemic scleroderma	0.000667	0.000895	CcSEcCtD
Cabergoline—Pneumonia—Methotrexate—systemic scleroderma	0.000666	0.000894	CcSEcCtD
Cabergoline—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000665	0.000893	CcSEcCtD
Cabergoline—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000663	0.00089	CcSEcCtD
Cabergoline—Rash—Azathioprine—systemic scleroderma	0.000661	0.000888	CcSEcCtD
Cabergoline—Dermatitis—Azathioprine—systemic scleroderma	0.000661	0.000887	CcSEcCtD
Cabergoline—Depression—Methotrexate—systemic scleroderma	0.00066	0.000887	CcSEcCtD
Cabergoline—Headache—Azathioprine—systemic scleroderma	0.000657	0.000882	CcSEcCtD
Cabergoline—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000656	0.000881	CcSEcCtD
Cabergoline—Dizziness—Leflunomide—systemic scleroderma	0.000655	0.000879	CcSEcCtD
Cabergoline—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000648	0.00087	CcSEcCtD
Cabergoline—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000647	0.000868	CcSEcCtD
Cabergoline—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000638	0.000856	CcSEcCtD
Cabergoline—Pain—Mycophenolate mofetil—systemic scleroderma	0.000638	0.000856	CcSEcCtD
Cabergoline—Arrhythmia—Prednisone—systemic scleroderma	0.000636	0.000853	CcSEcCtD
Cabergoline—Vomiting—Leflunomide—systemic scleroderma	0.00063	0.000845	CcSEcCtD
Cabergoline—Alopecia—Prednisone—systemic scleroderma	0.000629	0.000844	CcSEcCtD
Cabergoline—Hypersensitivity—Lisinopril—systemic scleroderma	0.000627	0.000842	CcSEcCtD
Cabergoline—Dizziness—Mycophenolic acid—systemic scleroderma	0.000625	0.000839	CcSEcCtD
Cabergoline—Epistaxis—Methotrexate—systemic scleroderma	0.000625	0.000839	CcSEcCtD
Cabergoline—Rash—Leflunomide—systemic scleroderma	0.000625	0.000838	CcSEcCtD
Cabergoline—Dermatitis—Leflunomide—systemic scleroderma	0.000624	0.000838	CcSEcCtD
Cabergoline—Nausea—Azathioprine—systemic scleroderma	0.000623	0.000836	CcSEcCtD
Cabergoline—Headache—Leflunomide—systemic scleroderma	0.000621	0.000833	CcSEcCtD
Cabergoline—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000615	0.000825	CcSEcCtD
Cabergoline—Asthenia—Lisinopril—systemic scleroderma	0.000611	0.00082	CcSEcCtD
Cabergoline—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00061	0.000819	CcSEcCtD
Cabergoline—Pruritus—Lisinopril—systemic scleroderma	0.000602	0.000808	CcSEcCtD
Cabergoline—Vomiting—Mycophenolic acid—systemic scleroderma	0.000601	0.000807	CcSEcCtD
Cabergoline—Rash—Mycophenolic acid—systemic scleroderma	0.000596	0.0008	CcSEcCtD
Cabergoline—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000595	0.000799	CcSEcCtD
Cabergoline—Headache—Mycophenolic acid—systemic scleroderma	0.000592	0.000795	CcSEcCtD
Cabergoline—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00059	0.000791	CcSEcCtD
Cabergoline—Nausea—Leflunomide—systemic scleroderma	0.000588	0.00079	CcSEcCtD
Cabergoline—Diarrhoea—Lisinopril—systemic scleroderma	0.000582	0.000782	CcSEcCtD
Cabergoline—Ill-defined disorder—Prednisone—systemic scleroderma	0.000575	0.000771	CcSEcCtD
Cabergoline—Visual impairment—Methotrexate—systemic scleroderma	0.000573	0.000769	CcSEcCtD
Cabergoline—Dizziness—Lisinopril—systemic scleroderma	0.000563	0.000756	CcSEcCtD
Cabergoline—Nausea—Mycophenolic acid—systemic scleroderma	0.000561	0.000753	CcSEcCtD
Cabergoline—Malaise—Prednisone—systemic scleroderma	0.000559	0.00075	CcSEcCtD
Cabergoline—Vertigo—Prednisone—systemic scleroderma	0.000556	0.000747	CcSEcCtD
Cabergoline—Syncope—Prednisone—systemic scleroderma	0.000555	0.000746	CcSEcCtD
Cabergoline—Cardiac disorder—Methotrexate—systemic scleroderma	0.000552	0.000741	CcSEcCtD
Cabergoline—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000549	0.000738	CcSEcCtD
Cabergoline—Loss of consciousness—Prednisone—systemic scleroderma	0.000544	0.000731	CcSEcCtD
Cabergoline—Vomiting—Lisinopril—systemic scleroderma	0.000541	0.000726	CcSEcCtD
Cabergoline—Rash—Lisinopril—systemic scleroderma	0.000537	0.00072	CcSEcCtD
Cabergoline—Dermatitis—Lisinopril—systemic scleroderma	0.000536	0.00072	CcSEcCtD
Cabergoline—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000535	0.000718	CcSEcCtD
Cabergoline—Hypertension—Prednisone—systemic scleroderma	0.000535	0.000718	CcSEcCtD
Cabergoline—Headache—Lisinopril—systemic scleroderma	0.000533	0.000716	CcSEcCtD
Cabergoline—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000528	0.000708	CcSEcCtD
Cabergoline—Arthralgia—Prednisone—systemic scleroderma	0.000527	0.000708	CcSEcCtD
Cabergoline—Anxiety—Prednisone—systemic scleroderma	0.000525	0.000705	CcSEcCtD
Cabergoline—Alopecia—Methotrexate—systemic scleroderma	0.000525	0.000705	CcSEcCtD
Cabergoline—Discomfort—Prednisone—systemic scleroderma	0.000521	0.000699	CcSEcCtD
Cabergoline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00051	0.000685	CcSEcCtD
Cabergoline—Nausea—Lisinopril—systemic scleroderma	0.000506	0.000679	CcSEcCtD
Cabergoline—Oedema—Prednisone—systemic scleroderma	0.000506	0.000679	CcSEcCtD
Cabergoline—Back pain—Methotrexate—systemic scleroderma	0.000501	0.000672	CcSEcCtD
Cabergoline—Shock—Prednisone—systemic scleroderma	0.000497	0.000668	CcSEcCtD
Cabergoline—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000493	0.000662	CcSEcCtD
Cabergoline—Hyperhidrosis—Prednisone—systemic scleroderma	0.000489	0.000656	CcSEcCtD
Cabergoline—Anorexia—Prednisone—systemic scleroderma	0.000482	0.000647	CcSEcCtD
Cabergoline—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00048	0.000645	CcSEcCtD
Cabergoline—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000474	0.000637	CcSEcCtD
Cabergoline—Rash—Mycophenolate mofetil—systemic scleroderma	0.00047	0.000631	CcSEcCtD
Cabergoline—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00047	0.000631	CcSEcCtD
Cabergoline—Headache—Mycophenolate mofetil—systemic scleroderma	0.000467	0.000627	CcSEcCtD
Cabergoline—Malaise—Methotrexate—systemic scleroderma	0.000467	0.000627	CcSEcCtD
Cabergoline—Vertigo—Methotrexate—systemic scleroderma	0.000465	0.000624	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000461	0.000618	CcSEcCtD
Cabergoline—Insomnia—Prednisone—systemic scleroderma	0.000457	0.000614	CcSEcCtD
Cabergoline—Paraesthesia—Prednisone—systemic scleroderma	0.000454	0.000609	CcSEcCtD
Cabergoline—Dyspepsia—Prednisone—systemic scleroderma	0.000445	0.000597	CcSEcCtD
Cabergoline—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000443	0.000595	CcSEcCtD
Cabergoline—Arthralgia—Methotrexate—systemic scleroderma	0.000441	0.000592	CcSEcCtD
Cabergoline—Decreased appetite—Prednisone—systemic scleroderma	0.000439	0.00059	CcSEcCtD
Cabergoline—Fatigue—Prednisone—systemic scleroderma	0.000436	0.000585	CcSEcCtD
Cabergoline—Discomfort—Methotrexate—systemic scleroderma	0.000435	0.000585	CcSEcCtD
Cabergoline—Constipation—Prednisone—systemic scleroderma	0.000432	0.00058	CcSEcCtD
Cabergoline—Confusional state—Methotrexate—systemic scleroderma	0.000426	0.000572	CcSEcCtD
Cabergoline—Feeling abnormal—Prednisone—systemic scleroderma	0.000417	0.000559	CcSEcCtD
Cabergoline—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000413	0.000555	CcSEcCtD
Cabergoline—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000408	0.000548	CcSEcCtD
Cabergoline—Anorexia—Methotrexate—systemic scleroderma	0.000403	0.000541	CcSEcCtD
Cabergoline—Abdominal pain—Prednisone—systemic scleroderma	0.0004	0.000536	CcSEcCtD
Cabergoline—Hypotension—Methotrexate—systemic scleroderma	0.000395	0.00053	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000385	0.000517	CcSEcCtD
Cabergoline—Insomnia—Methotrexate—systemic scleroderma	0.000382	0.000513	CcSEcCtD
Cabergoline—Paraesthesia—Methotrexate—systemic scleroderma	0.000379	0.000509	CcSEcCtD
Cabergoline—Dyspnoea—Methotrexate—systemic scleroderma	0.000377	0.000506	CcSEcCtD
Cabergoline—Somnolence—Methotrexate—systemic scleroderma	0.000376	0.000504	CcSEcCtD
Cabergoline—Hypersensitivity—Prednisone—systemic scleroderma	0.000372	0.0005	CcSEcCtD
Cabergoline—Dyspepsia—Methotrexate—systemic scleroderma	0.000372	0.000499	CcSEcCtD
Cabergoline—Decreased appetite—Methotrexate—systemic scleroderma	0.000367	0.000493	CcSEcCtD
Cabergoline—Fatigue—Methotrexate—systemic scleroderma	0.000364	0.000489	CcSEcCtD
Cabergoline—Asthenia—Prednisone—systemic scleroderma	0.000363	0.000487	CcSEcCtD
Cabergoline—Pain—Methotrexate—systemic scleroderma	0.000361	0.000485	CcSEcCtD
Cabergoline—Pruritus—Prednisone—systemic scleroderma	0.000358	0.00048	CcSEcCtD
Cabergoline—Feeling abnormal—Methotrexate—systemic scleroderma	0.000348	0.000467	CcSEcCtD
Cabergoline—Diarrhoea—Prednisone—systemic scleroderma	0.000346	0.000464	CcSEcCtD
Cabergoline—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000345	0.000464	CcSEcCtD
Cabergoline—Dizziness—Prednisone—systemic scleroderma	0.000334	0.000449	CcSEcCtD
Cabergoline—Abdominal pain—Methotrexate—systemic scleroderma	0.000334	0.000448	CcSEcCtD
Cabergoline—Vomiting—Prednisone—systemic scleroderma	0.000321	0.000431	CcSEcCtD
Cabergoline—Rash—Prednisone—systemic scleroderma	0.000319	0.000428	CcSEcCtD
Cabergoline—Dermatitis—Prednisone—systemic scleroderma	0.000318	0.000427	CcSEcCtD
Cabergoline—Headache—Prednisone—systemic scleroderma	0.000317	0.000425	CcSEcCtD
Cabergoline—Hypersensitivity—Methotrexate—systemic scleroderma	0.000311	0.000418	CcSEcCtD
Cabergoline—Asthenia—Methotrexate—systemic scleroderma	0.000303	0.000407	CcSEcCtD
Cabergoline—Nausea—Prednisone—systemic scleroderma	0.0003	0.000403	CcSEcCtD
Cabergoline—Pruritus—Methotrexate—systemic scleroderma	0.000299	0.000401	CcSEcCtD
Cabergoline—Diarrhoea—Methotrexate—systemic scleroderma	0.000289	0.000388	CcSEcCtD
Cabergoline—Dizziness—Methotrexate—systemic scleroderma	0.000279	0.000375	CcSEcCtD
Cabergoline—Vomiting—Methotrexate—systemic scleroderma	0.000269	0.000361	CcSEcCtD
Cabergoline—Rash—Methotrexate—systemic scleroderma	0.000266	0.000358	CcSEcCtD
Cabergoline—Dermatitis—Methotrexate—systemic scleroderma	0.000266	0.000357	CcSEcCtD
Cabergoline—Headache—Methotrexate—systemic scleroderma	0.000265	0.000355	CcSEcCtD
Cabergoline—Nausea—Methotrexate—systemic scleroderma	0.000251	0.000337	CcSEcCtD
